Point-of-Care (POC) Coagulation Testing Market Growth Outlook Through 2024-2033

Overview and Scope
Point-of-care (POC) coagulation testing refers to diagnostic tests that assess blood clotting function performed at the patient's bedside or near the site of care, rather than in a centralized laboratory. It is used to provide real-time or near-real-time results (within minutes), significantly faster than traditional lab tests, that allow healthcare professionals to make quicker treatment decisions and optimize anticoagulation therapy.

Sizing and Forecast
The point-of-care (POC) coagulation testing market size has grown strongly in recent years. It will grow from $1.12 billion in 2023 to $1.18 billion in 2024 at a compound annual growth rate (CAGR) of 5.9%.  The growth in the historic period can be attributed to rise in patient demand, growing trend of point-of-care testing, high reliability of coagulation status on pt test, automation and integration with electronic health records (EHRs), rising incidence of cardiovascular diseases and blood disorders.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/point-of-care-poc-coagulation-testing-global-market-report

Segmentation & Regional Insights
The point-of-care (poc) coagulation testing market covered in this report is segmented –
1) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology
2) By Distribution Channel: Direct Tenders, Retail
3) By End-User: Hospitals, Clinics, Home care

North America was the largest region in the point-of-care (POC) coagulation testing market in 2023. The regions covered in the point-of-care (poc) coagulation testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13913&type=smp

Major Driver Impacting Market Growth
The rising incidence of cardiovascular diseases is expected to propel the growth of the point-of-care (POC) coagulation testing market going forward. Cardiovascular diseases (CVDs) refer to a group of disorders of the heart and blood vessels, including conditions such as coronary heart disease, cerebrovascular disease, and peripheral arterial disease. Point-of-care (POC) coagulation testing is helpful in the treatment of cardiovascular diseases (CVDs) as it provides real-time information on coagulation status, enabling timely decision-making on coagulation interventions and reducing the risk of bleeding complications after cardiac surgery. For instance, in May 2023, according to the Centers for Disease Control and Prevention, a US-based government agency, in the United States, heart disease claimed the lives of about 695,000 people in 2021, accounting for 1 in 5 fatalities. Further, coronary heart disease is the most common type of heart disease, killing 375,476 people in 2021. Therefore, the rising incidence of cardiovascular diseases is driving the growth of the point-of-care (POC) coagulation testing market.

Key Industry Players
Major companies operating in the point-of-care (poc) coagulation testing market report are AT&T Corporation, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Medtronic Plc, Koninklijke Philips N.V., Sysmex Corporation, IDEXX Laboratories Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Teleflex Incorporated, Werfen SA, Nihon Kohden Corporation, Horiba Ltd., Hycel, Nova Biomedical Corporation, Haemonetics Corporation, Maccura Biotechnology Co. Ltd., Helena Laboratories Corporation, Abaxis Inc., ARKRAY Inc., Radiometer Medical ApS, HemoSonics LLC, iLine Microsystems SL, Corgenix Medical Corporation, Quotient Limited, Micropoint Bioscience Inc., Beijing Succeeder Technology Inc., EKF Diagnostics Holdings plc

The point-of-care (poc) coagulation testing market report table of contents includes:
1. Executive Summary

2. Point-of-Care (POC) Coagulation Testing Market Characteristics
3. Point-of-Care (POC) Coagulation Testing Market Trends And Strategies
4. Point-of-Care (POC) Coagulation Testing Market – Macro Economic Scenario
5. Global Point-of-Care (POC) Coagulation Testing Market Size and Growth

…..

31. Global Point-of-Care (POC) Coagulation Testing Market Competitive Benchmarking
32. Global Point-of-Care (POC) Coagulation Testing Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Point-of-Care (POC) Coagulation Testing Market
34. Point-of-Care (POC) Coagulation Testing Market Future Outlook and Potential Analysis
35. Appendix

Explore the trending research reports from TBRC:
https://topprnews.com/cloud-load-balancers-market

https://topprnews.com/online-assessment-software-market

https://topprnews.com/zero-touch-provisioning-market

https://goodprnews.com/denosumab-global-market

https://goodprnews.com/cryotherapy-global-market

https://goodprnews.com/active-geofencing-global-market

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info

Healthcare Blog: https://healthcareresearchreports.com

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

santhoshtbrc Member since March 19, 2024